申请人:Koga Yuji
公开号:US20100113391A1
公开(公告)日:2010-05-06
[Problem]
Provided is a compound, which exhibits a P2Y12 inhibitory action and is useful as a medical drug, particularly, as a platelet aggregation inhibitor.
[Means for Solution]
The inventors have eagerly investigated P2Y12 inhibitors. As a result, the inventors have found that a bicyclic heterocyclic compound such as quinazolinedione, isoquinolone, and the like having an amino group substituted with lower alkyl, cycloalkyl, or lower alkylene-cycloalkyl at the specific position exhibits an excellent platelet aggregation inhibitory action, thereby completing the present invention. Since the compound of the invention exhibits excellent P2Y12 inhibitory action and platelet aggregation inhibitory action, it is useful as a platelet aggregation inhibitor.
[问题] 提供的是一种化合物,它表现出P2Y12抑制作用,可用作医药,特别是血小板聚集抑制剂。
[解决方法] 发明者们积极研究P2Y12抑制剂。结果,发明者们发现,具有氨基固定在特定位置的低烷基,环烷基或低烷基-环烷基的类似于喹唑啉二酮,异喹啉等的双环杂环化合物表现出优异的血小板聚集抑制作用,从而完成了本发明。由于本发明的化合物表现出优异的P2Y12抑制作用和血小板聚集抑制作用,因此它可用作血小板聚集抑制剂。